Péptidos

CMVpp65 - 9 is a custom research peptide; min purity 95%, TFA salt. For different specs please use the Peptide Quote Tool

A synthetic peptide for use as a blocking control in assays to test for specificity of APP antibody, catalog no. 70R-6195

Peptide H-SIIPR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice.

Leptin (57 - 74) is a custom research peptide; min purity 95%, TFA salt. For different specs please use the Peptide Quote Tool

A synthetic peptide for use as a blocking control in assays to test for specificity of KCNV2 antibody, catalog no. 70R-5119

A synthetic peptide for use as a blocking control in assays to test for specificity of TH1L antibody, catalog no. 70R-9546

A synthetic peptide for use as a blocking control in assays to test for specificity of Htr3a antibody, catalog no. 70R-8076

A synthetic peptide for use as a blocking control in assays to test for specificity of HSD17B14 antibody, catalog no. 70R-3811

A synthetic peptide for use as a blocking control in assays to test for specificity of TINF2 antibody, catalog no. 70R-2620

A synthetic peptide for use as a blocking control in assays to test for specificity of C5orf36 antibody, catalog no. 70R-4264

A synthetic peptide for use as a blocking control in assays to test for specificity of SLC1A1 antibody, catalog no. 70R-6796

A synthetic peptide for use as a blocking control in assays to test for specificity of DDOST antibody, catalog no. 70R-1895

A synthetic peptide for use as a blocking control in assays to test for specificity of FAM20A antibody, catalog no. 70R-7418

A synthetic peptide for use as a blocking control in assays to test for specificity of Mkx antibody, catalog no. 70R-8448

A synthetic peptide for use as a blocking control in assays to test for specificity of RAB35 antibody, catalog no. 70R-9157

A synthetic peptide for use as a blocking control in assays to test for specificity of C16orf46 antibody, catalog no. 70R-4158

A synthetic peptide for use as a blocking control in assays to test for specificity of RBMS3 antibody, catalog no. 70R-1317

A synthetic peptide for use as a blocking control in assays to test for specificity of GTL3 antibody, catalog no. 70R-8024

A synthetic peptide for use as a blocking control in assays to test for specificity of SYCP3 antibody, catalog no. 70R-2271

A synthetic peptide for use as a blocking control in assays to test for specificity of TPM1 antibody, catalog no. 70R-2010

A synthetic peptide for use as a blocking control in assays to test for specificity of Ece2 antibody, catalog no. 70R-8607

A synthetic peptide for use as a blocking control in assays to test for specificity of IL1RL1 antibody, catalog no. 70R-7411

Peptide Elicitor peptide AtPep1 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice.

A synthetic peptide for use as a blocking control in assays to test for specificity of UBLCP1 antibody, catalog no. 70R-3747

A synthetic peptide for use as a blocking control in assays to test for specificity of ARG1 antibody, catalog no. 70R-1085

A synthetic peptide for use as a blocking control in assays to test for specificity of PEX11A antibody, catalog no. 70R-6610

A synthetic peptide for use as a blocking control in assays to test for specificity of FXYD5 antibody, catalog no. 70R-1683

Peptide H-YKQTSV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice.

Peroxiredoxin-2 is a protein that belongs to the peroxidase family of enzymes. It has been shown to be an activator of ion channels, which suggests that it may play a role in cell regulation. Peroxiredoxin-2 has also been shown to bind to peptides and antibodies, with potential therapeutic applications.

A synthetic peptide for use as a blocking control in assays to test for specificity of PSPH antibody, catalog no. 70R-4329

A synthetic peptide for use as a blocking control in assays to test for specificity of TRIM17 antibody, catalog no. 70R-8039

A synthetic peptide for use as a blocking control in assays to test for specificity of LSM6 antibody, catalog no. 70R-4929

A synthetic peptide for use as a blocking control in assays to test for specificity of Zfp90 antibody, catalog no. 70R-7903

A synthetic peptide for use as a blocking control in assays to test for specificity of SMPD3 antibody, catalog no. 70R-7194

A synthetic peptide for use as a blocking control in assays to test for specificity of DOK7 antibody, catalog no. 70R-10372

A synthetic peptide for use as a blocking control in assays to test for specificity of CGB antibody, catalog no. 70R-9986

Bis-dPEG®2-Acid is a PEG polymer categorised as homobifunctional PEG (X-PEG X). Used as a linker, bis-dPEG®2-Acid is used to attached PEG to proteins, peptides, oligonucleotides, nanoparticles and small molecules via pegylation, a bioconjugation technique.

A synthetic peptide for use as a blocking control in assays to test for specificity of C1orf43 antibody, catalog no. 70R-3822

A synthetic peptide for use as a blocking control in assays to test for specificity of PRPSAP2 antibody, catalog no. 70R-9397

Peptide Melanocyte Protein PMEL 17 (256-264) (human, bovine, mouse) is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice.

A synthetic peptide for use as a blocking control in assays to test for specificity of TM9SF1 antibody, catalog no. 70R-9642

Cancer antigen 125 (CA 125) light tryptic peptide standard for proteomics studies. CA 125 is an antigenic tumor marker which can be used to diagnose epithelial ovarian cancers. It is expressed by epithelial ovarian neoplasms and cells lining the fallopian tubes, endometrium, pericardium, peritoneum and pleura.

A synthetic peptide for use as a blocking control in assays to test for specificity of PNPLA3 antibody, catalog no. 70R-2371

A synthetic peptide for use as a blocking control in assays to test for specificity of SLC33A1 antibody, catalog no. 70R-6798

m-dPEG®24-Propionaldehyde is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. m-dPEG®24-Propionaldehyde is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.

Peptide PEP1 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice.

Human-monoFITC (PheB1) is a peptide with the amino acid sequence Phe-B1. It is a fluorescent ligand that is used as a research tool for receptor binding studies. The antibody conjugated to human-monoFITC (PheB1) can be used to detect and quantify the protein in Western blots.

Peptide H-EDVYVVGTVLR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice.

A synthetic peptide for use as a blocking control in assays to test for specificity of Tfdp1 antibody, catalog no. 70R-8289

A synthetic peptide for use as a blocking control in assays to test for specificity of FNTA antibody, catalog no. 70R-2956

A synthetic peptide for use as a blocking control in assays to test for specificity of TPR antibody, catalog no. 70R-10240

A synthetic peptide for use as a blocking control in assays to test for specificity of PCDH15 antibody, catalog no. 70R-6995

Nav1.7 selective blocker

A synthetic peptide for use as a blocking control in assays to test for specificity of Fmr1 antibody, catalog no. 70R-8477

A synthetic peptide for use as a blocking control in assays to test for specificity of RCC2 antibody, catalog no. 70R-3169

A synthetic peptide for use as a blocking control in assays to test for specificity of NUBP1 antibody, catalog no. 70R-9387

Agonist of µ-opoid receptor

A synthetic peptide for use as a blocking control in assays to test for specificity of POLDIP3 antibody, catalog no. 70R-4847

Angiotensin converting enzyme (ACE) heavy tryptic peptide standard for use in proteomics studies. ACE is involved in the regulation of blood pressure through converting inactive angiotensin I to active angiotensin II and also degrading active Bradykinin.

Inhibitor of the binding of α1β1 integrin to collagen IV

A synthetic peptide for use as a blocking control in assays to test for specificity of MRPL45 antibody, catalog no. 70R-10085

CCL2 (Chemokine C-C Motif Ligand 2), also known as monocyte chemoattractant protein 1 (MCP1) or small inducible cytokine A2 (SCYA2), is a protein classified as a chemotactic cytokine or chemokine. CCL2 binds to the chemokine receptors CCR2 and CCR5.
CCL2 belongs to the CC chemokine family, small soluble proteins whose main function is to regulate cell trafficking and that act as molecular signals to induce cellular migration during inflammation.
Chemokines are secreted in response to signals such as proinflammatory cytokines and induce chemotaxis through the activation of G-protein-coupled receptors (GPCRs), which involves adhesion molecules and glycosaminoglycans.
CCL2 is produced by a lot of cell types (endothelial, fibroblasts, epithelial, smooth muscle, monocytic, and microglial cells which are important for antiviral immune responses and in tissue), often after induction by oxidative stress, cytokines or growth factors.
Unlike other chemokines such as RANTES, CCL2 exhibits a chemotactic activity only for monocytes, T-cells, basophils, NK cells and immature dendritic cells. CCL2 doesn’t attract and activate neutrophils or eosinophils.
But like RANTES, CCL2 has the ability to target memory T-cells, which is not the case with other chemokines.

A synthetic peptide for use as a blocking control in assays to test for specificity of DHODH antibody, catalog no. 70R-6503

Muscle-type nAChRs blocker

Universal Major Histocompatibility Complex (MHC) H2 I-Ab epitope for CD4+ T-cell recruitment and activation
SB-PEPTIDE offers I-Ab restricted PADRE peptide ak(Cha)VAAWTLKAAa-Ahx-C.
Pan DR-binding epitope (PADRE) is a universal synthetic peptide binding Major Histocompatibility Complex (MHC)-II receptors, of which H2 complex (mouse MHC), present on specific immune cells. 4 class II loci exist in the region I of the H2 complex gene (see image below), known as Aa & Ea loci (α encoded) and Ab & Eb loci (β encoded), that are similar to the DR, DP and DQ loci of the Human Leukocyte Antigen (HLA) complex.
I-Ab restricted PADRE peptide interacts specifically with mouse H2-I-Ab receptors that activate antigen specific CD4+ T-cells in the same way as PADRE peptide’s interaction with HLA-DR receptors. This feature places I-Ab restricted PADRE as promising adjuvant for immunotherapeutic vaccines against chronicle diseases such as infections, Alzheimer or cancer. Similarly to the original PADRE peptide, the restricted version also acts as a Toll-like receptor (TLR) agonist and was described as alternative carrier, such as KLH/BSA or OVA, for prophylaxis and therapeutic vaccines. An aminocaproic acid (Ahx) linker, attached to an additional C-terminal Cysteine, was added to the sequence to allow both the peptide and its loading to interact independently and freely with molecules exposed to them. This modification is used for the loading of antigenic determinants in solution in order to enhance the immune response against a specific antigen (AG).

A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF524 antibody, catalog no. 70R-8443

A synthetic peptide for use as a blocking control in assays to test for specificity of DPY19L2 antibody, catalog no. 70R-7084

A synthetic peptide for use as a blocking control in assays to test for specificity of KNG1 antibody, catalog no. 70R-2920

A synthetic peptide for use as a blocking control in assays to test for specificity of SNRP70 antibody, catalog no. 70R-1431

A synthetic peptide for use as a blocking control in assays to test for specificity of SIGIRR antibody, catalog no. 70R-6630

MAGE-A3 (195-203) peptide – IMPKAGLLI – Epitope of Melanoma Antigen Gene A3

A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF385D antibody, catalog no. 70R-8969

Biotin-SARS-CoV-2 Spike RBD 371-394 peptide is the biotinylated version of SARS-CoV-2 Spike RBD 371-394 peptide. SARS-CoV-2 Spike RBD 371-394 peptide is an epitope of interest of the SARS-CoV-2 Spike S glycoprotein Receptor-Binding Domain (RBD). Biotin-SARS-CoV-2 Spike RBD 371-394 peptide is useful for vaccine development and for structure-activity relationship studies
SARS-CoV-2 Spike (S) glycoprotein
Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells.
With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane.
SARS-CoV-2 Spike RBD:
The receptor-binding domain in SARS-CoV-2 Spike protein allows binding to the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry.

A synthetic peptide for use as a blocking control in assays to test for specificity of RNF121 antibody, catalog no. 70R-1778

Voltage-gated sodium channels blocker

A synthetic peptide for use as a blocking control in assays to test for specificity of EIF3F antibody, catalog no. 70R-10402

A synthetic peptide for use as a blocking control in assays to test for specificity of CLPTM1L antibody, catalog no. 70R-7327

A synthetic peptide for use as a blocking control in assays to test for specificity of RPS21 antibody, catalog no. 70R-2535

A synthetic peptide for use as a blocking control in assays to test for specificity of TSSK2 antibody, catalog no. 70R-2083

A synthetic peptide for use as a blocking control in assays to test for specificity of REG1B antibody, catalog no. 70R-5333

A synthetic peptide for use as a blocking control in assays to test for specificity of C20orf111 antibody, catalog no. 70R-4348

Biotin-SARS-CoV-2 Spike RBD 319-335 peptide is the biotinylated version of SARS-CoV-2 Spike RBD 319-335 peptide. SARS-CoV-2 Spike RBD 319-335 peptide is an epitope of interest of the SARS-CoV-2 Spike S glycoprotein Receptor-Binding Domain (RBD). Biotin-SARS-CoV-2 Spike RBD 319-335 peptide is useful for vaccine development and for structure-activity relationship studies
SARS-CoV-2 Spike (S) glycoprotein
Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells.
With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane.
SARS-CoV-2 Spike RBD:
The receptor-binding domain in SARS-CoV-2 Spike protein allows binding to the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry.

A synthetic peptide for use as a blocking control in assays to test for specificity of DRGX antibody, catalog no. 70R-8703

A synthetic peptide for use as a blocking control in assays to test for specificity of SERAC1 antibody, catalog no. 70R-10152

A synthetic peptide for use as a blocking control in assays to test for specificity of FXYD5 antibody, catalog no. 70R-1682

A synthetic peptide for use as a blocking control in assays to test for specificity of LDB3 antibody, catalog no. 70R-1141

Clickable TAT peptide.

Angiotensin II plays an essential role in the maintenance of blood pressure and blood volume. It is a peptide hormone that causes vasoconstriction, a sensation of thirst, and stimulation of the adrenal cortex and aldosterone.
Derived from the cleavage of angiotensin I by the angiotensin converting enzyme, angiotensin II is involved in the renin-angiotensin system (RAS).
Angiotensin II is the subject of much scientific research and is already the target of many anti-hypertensive drugs (ACE inhibitors, ARBs or AT1 receptor antagonists).

A synthetic peptide for use as a blocking control in assays to test for specificity of DCUN1D3 antibody, catalog no. 70R-3679

SIL peptide for Adalimumab detection and quantification

A synthetic peptide for use as a blocking control in assays to test for specificity of GRM6 antibody, catalog no. 70R-7886

A synthetic peptide for use as a blocking control in assays to test for specificity of PNKP antibody, catalog no. 70R-4477

Blocker of Kv4.2 and Kv4.3 channels

A synthetic peptide for use as a blocking control in assays to test for specificity of SFRS3 antibody, catalog no. 70R-4718

CMV pp65 protein:
CMV pp65 (113-121) is an epitope of the main component of the enveloped subviral particle pp65 (phosphoprotein ppUL83) of Cytomegalovirus, member of herpes virus group. CMV pp65 antigens are used as target for the diagnosis of concomitant CMV end-organ disease. CMV specific cytotoxic T lymphocyte response is highly focused to pp65 in the context of HLA-A24:02.
Applications of CMV pp65 (113-121):
CMV pp65 (113-121) is used to stimulate peptide-specific CTL response and to analyze interferon γ production by flow cytometry and ELISPOT assay. CMV pp65 (113-121) contains HLA-A24 binding site and elicits CMV pp65 (113-121)-specific CTL in PBMCs which recognize pp65 expressed on CMV-infected fibroblast of HLA-A24 positive patients. CMV pp65 (113-121) might be implicated in improvement of immunotherapeutic strategies for efficient vaccine development against HCMV.

MBP (Myelin Basic Protein – UniProtKB – P04370) is a major constituent of the myelin in nerves. This protein permits the maintain of the myelin structure. MBP contains various epitopes implicated in Multiple Sclerosis.
MBP (84-97) induces EAE

A synthetic peptide for use as a blocking control in assays to test for specificity of LBX2 antibody, catalog no. 70R-8694

A synthetic peptide for use as a blocking control in assays to test for specificity of ZFP28 antibody, catalog no. 70R-8349

Fluorescent TAT peptide.